Evidence map›Paper›PMID 28139749›Full record

ArticleScientific reports2017

Germline large genomic alterations on 7q in patients with multiple primary cancers.

R A R Villacis, T R Basso, L M Canto, A F Nóbrega, M I Achatz, S R Rogatto

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact, top 99% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Acetylcholinesterase and human cancers.Advances in cancer research · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 2 countries.

R A R VillacisInternational Research Center (CIPE), A.C. Camargo Cancer Center, São Paulo, SP, Brazil.
T R BassoInternational Research Center (CIPE), A.C. Camargo Cancer Center, São Paulo, SP, Brazil.
L M CantoInternational Research Center (CIPE), A.C. Camargo Cancer Center, São Paulo, SP, Brazil.
A F NóbregaDepartment of Oncogenetics, A.C. Camargo Cancer Center, São Paulo, Brazil.
M I AchatzDepartment of Oncogenetics, A.C. Camargo Cancer Center, São Paulo, Brazil.
S R RogattoInternational Research Center (CIPE), A.C. Camargo Cancer Center, São Paulo, SP, Brazil.
AC Camargo Hospital · BR

Funding

Clinical Genetic Studies of Familial and Hereditary Cancer SyndromesZIACP010144 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI SAVAGE, SHARON A. · 2009 to 2025
$111.8M
6 · The paper itself

Abstract

Patients with multiple primary cancers (MPCs) are suspected to have a hereditary cancer syndrome. However, only a small proportion may be explained by mutations in high-penetrance genes. We investigate two unrelated MPC patients that met Hereditary Breast and Ovaria Cancer criteria, both presenting triple negative breast tumors and no mutations in BRCA1, BRCA2 and TP53 genes. Germline rearrangements on chromosome 7q, involving over 40 Mb of the same region, were found in both patients: one with mosaic loss (80% of cells) and the other with cnLOH (copy-neutral loss of heterozygosity) secondary to maternal allele duplication. Five children tested had no alterations on 7q. The patients shared 330 genes in common on 7q22.1-q34, including several tumor suppressor genes (TSGs) previously related to breast cancer risk and imprinted genes. The analysis of the triple negative BC from one patient revealed a mosaic gain of 7q translated for over-expressed cancer-related genes. The involvement of TSGs and imprinted genes, mapped on 7q, has the potential of being associated to MPC risk, as well as cancer progression. To our knowledge, this is the first description of patients with MPCs that harbor constitutive large alterations on 7q.

Indexed as

Chromosome AberrationsChromosomes, Human, Pair 7GenomicsGerm-Line MutationAdultFemaleGene Expression ProfilingGenes, BRCA1Genes, BRCA2Genetic Predisposition to DiseaseHumansMaleMiddle AgedMutationNeoplasms, Multiple PrimaryPedigreeTumor Suppressor Protein p53

Identifiers

PMID28139749
PMCPMC5282589
OpenAlexW2583861178

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.